The TouCAHn trial is an open-label, global, Phase 2 study designed to evaluate the efficacy, safety, and pharmacokinetics of ...

U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” third quarter 2024 ...

MERIDIAN, Calif. — The mother of an 11-year-old boy in Sutter County was arrested Sunday in connection with her child's death ...

It consists of a thin cartridge that you stick in your mouth for 60 seconds. It looks similar to a pregnancy test, with a ...

Corcept Therapeutics Incorporated (NASDAQ: CORT) has recently submitted a New Drug Application (NDA) to the U.S. Food and ...

CORT makes pipeline progress with the submission of a new drug application for relacorilant to treat patients with endogenous hypercortisolism.

Corcept Therapeutics Inc. (CORT) said that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for ...

Corcept Therapeutics submitted a new drug application to the Food and Drug Administration for its treatment of hypercortisolism, or Cushing's syndrome, a hormonal disorder that occurs when the body ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

A recent survey reveals a significant decline in teen drug and alcohol use since 2017, reaching its lowest point in 2024. Researchers attribute this drop to pandemic lockdowns disrupting social ...

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we are going to take a look at ...